Raphael Pharmaceutical (Raphael Pharmaceutical) General and Admin. Expense : $1.24 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Raphael Pharmaceutical General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Raphael Pharmaceutical's General and Admin. Expense for the three months ended in Dec. 2023 was $0.48 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $1.24 Mil.

Raphael Pharmaceutical General and Admin. Expense Historical Data

The historical data trend for Raphael Pharmaceutical's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raphael Pharmaceutical General and Admin. Expense Chart

Raphael Pharmaceutical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

General and Admin. Expense

0.25

0.85

2.14

0.70

Raphael Pharmaceutical Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
General and Admin. Expense	Get a 7-Day Free Trial								1.05	0.14	0.13	0.49	0.48

Raphael Pharmaceutical General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.24 Mil.

Raphael Pharmaceutical General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Raphael Pharmaceutical's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Raphael Pharmaceutical (Raphael Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Raphael Pharmaceutical Inc (OTCPK:RAPH) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Lui Paster, Tel Aviv-Jaffa, ISR, 6803605

Website

https://www.raphaelpharmaceutical.com

Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil.

Executives

Joseph Press	director	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Shlomo Pilo	director, 10 percent owner, officer: Chief Executive Officer	4 LUI PASTER, TEL AVIV L3 6803605
Hayon Igal Louria	director, officer: Chief Technology Officer	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Yehuda Eliya	director	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Robert B Catell	director	62 OSBORNE ROAD, GARDEN CITY NY 11530
Elisha Yanay	director	C/O ADVANCED TECHNOLOGY ACQUISITION CORP, 14 A ACHIMEIR STREET, RAMAT GAN L3 52587
Yacov A Shamash	director
Guy Ofir	director, 10 percent owner, officer: President	40 BAZ STREET, KARMIEL L3 20100
Emanuel Cohen	director, 10 percent owner, officer: Secretary Treasurer Director	51 BILU STREET, RA'ANANA L3 00000

Raphael Pharmaceutical (Raphael Pharmaceutical) Headlines

No Headlines